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1 SUMMARY 
 
Introduction  
Down syndrome (DS) represents the leading cause of intellectual disability (ID) of genetic 
origin and an important public health issue due to inability of affected individuals to live an 
independent life.  At the moment DS is an untreatable condition characterized by a number 
of developmental defects and permanent deficits in the adulthood. In addition, the biology 
of aging may be different in individuals with DS - there is an early-onset of Alzheimer’s 
disease (AD). Because of its complexity, many aspects of DS must be studied in both humans 
and animal models. In the present study, I focused on Ts65Dn mice, the best characterized 
and most widely used model of DS. Ts65Dn mice display severe cognitive and synaptic 
plasticity defects closely resembling the human phenotype. Recent findings in Ts65Dn mice 
have suggested that it is possible to rescue DS-related cognitive dysfunction in adulthood 
using environmental enrichment (EE), a paradigm of increased sensory-motor stimulation, 
throughout enhancement of neural plasticity. However, little is known about the 
therapeutic potential of EE in aged Ts65Dn mice and DS persons that display very complex 
cognitive phenotype in a form of AD dementia in the context of ID.  
Aims of the thesis  
The present study aims at providing initial evidence about the effects of long-term EE on 
cognitive performance in aged Ts65Dn mice. The principal objectives of the study were: 
1. Investigation of the effects of long-term EE on spatial learning and memory in 
aged Ts65Dn and aged-matched control WT mice by use of Morris water maze test 
(MWM); 
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2. Investigation of the effects of long-term EE on short-term working memory in aged 
Ts65Dn and aged-matched control WT mice by use of  Y maze test. 
Materials and methods  
Animals: In this study was used the transgenic line Ts65Dn that carries segmental trisomy in 
a form of Robertsonian translocation of Mmu16 to Mmu17 (1716). Segmental trisomy 
provokes male sterility, therefore female carriers of the 1716 chromosome are used to 
generate trisomic offspring by intercross with hybrid male mice. Real time PCR genotyping 
assay was used to genotype the progeny. Intervention: EE consisted in a complex rearing 
environment composed of motor, sensory, cognitive and social stimulation; mice were 
housed in large cages equipped with various objects that are completely replaced with 
others once per week. Behavioral assessment: the effects of intervention on spatial memory 
and learning was evaluated by MWM test, while the effects on short term working memory 
was evaluated by Y maze test. Statistics: statistical analysis were performed using SigmaStat 
Software. 
Results and conclusions  
My results demonstrated that long-term EE led to significant behavioral benefits in aged 
Ts65Dn such as facilitation of spatial learning and memory function in MWM and increased 
explorative behavior in Y maze. MWM test showed that long-term EE was able not only to 
prevent additional age-associated cognitive decline of already poor cognitive performance 
evident in young trisomic mice, but to completely rescue spatial learning in aged Ts65Dn 
mice. This is a first evidence that long-term EE may be successfully employed to reverse 
cognitive deficits in aged Ts65Dn mice.  
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Given a non-invasive nature of EE paradigm, it would be of great clinical and social 
interest to perform novel studies that will explore the potential of increased environmental 
stimulation to ameliorate existing cognitive defects and to prevent additional cognitive 
decline in aging DS subjects. 
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2 INTRODUCTION 
 
 2.1. DOWN SYNDROME – INSIGHTS FROM MURINE MODEL  
 
Down syndrome (DS) is a genetic pathology caused by triplication of chromosome 21 
(Hsa21) and is characterized by a number of physical and mental abnormalities, with 
intellectual disability (ID) as the most serious health problem. Complexity of  DS arises from 
the substantial genetic basis of syndrome, the dysfunction of multiple systems and the high 
phenotypic variability of its clinical manifestations among affected individuals (Antonarakis 
and Epstein, 2006). Virtually all people living with DS have a triplication of at least one 
segment of Hsa21 being responsible for inappropriate development and resulting in 
structural and functional anomalies that persist throughout the entire lifespan. Beside the 
disruption of development, trisomic gene expression affects also the properties of 
differentiated adult cells, compromising further their already altered functions. 
Sequencing of Hsa21 and identification of its mouse ortholog genes (Pletcher et al., 
2001) have led to generation of transgenic mice that have enabled remarkable advances in 
better understanding of the DS nature. The mouse is the organism of choice in modern 
biomedical research as it allows a vast degree of genetic alteration, high reproducibility of 
experiments due to the breeding simplicity and use of intrusive studies. Respect to human 
genome, orthologs in mouse differ minimally in the structures of conserved genes (Gardiner 
and Davisson, 2000), although differences in regulation of gene expression may be expected 
(Gharib and Robinson-Rechavi, 2011). Importantly, developmental programs and basic 
mechanisms of mature functions are conserved across mammals. In line with this is the 
occurrence of DS like phenotype in mice trisomic for Hsa21 orthologs (Das and Reeves, 
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2011). 
The advantage of DS mouse models for translational research is not only a successful 
recapitulation of disease aspects, but also a predictive ability, i.e. certain phenotypic 
abnormalities for the first time observed in trisomic mice have been confirmed later in DS 
patients (Belichenko et al., 2004). Moreover, systematic investigation of these models 
enables a more precise definition of genotype-phenotype interaction, better understanding 
of altered molecular pathways and identification of potential therapeutic targets, and finally 
design of preclinical studies with treatments likely to be tested in clinical trials. 
 
2.1.1. THE HUMAN TRISOMY 21 
 
DS is a complex clinical entity caused by trisomy of Hsa21 (T21) and characterized by 
numerous features affecting multiple systems, with cognitive impairment as the most 
prominent and deleterious symptom. With the prevalence of 1 in 850-1000 infants (Shin et 
al., 2009) DS represents the leading cause of ID of genetic origin (Lott and Dierssen, 2010) 
and an important public health issue due to inability of affected individuals to live an 
independent life. DS was described for the first time in 1866 by John Langdon Down, but the 
link of its numerous features with T21 was revealed only later in 1959 by the cytological 
profiling study performed by Jerome Lejeune (Megarbane et al., 2009). In the majority of 
cases DS is caused by the full T21 (95%), but the occurrence of two other genetic variations 
including translocation T21 (4%) and mosaic T21 (1%) also gives rise to DS phenotype 
(Parker et al., 2010). The full T21 is due to a meiotic nondisjunction of Hsa21 that is related 
to an advanced age of mother in about 75% of DS cases, while in remaining 25% it has 
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paternal origin (Turleau and Vekemans, 2010). This nondisjunction seems to be associated 
with errors in recombination and an age-dependent loss of meiotic chromosome cohesion 
(Hassold and Hunt, 2001, Hodges and Wallace, 2005), but why these recombinant mistakes 
take place and how their consequential burden of DS could be avoided it is still far away 
from being understood.      
The presence of an additional copy of Hsa21 implicates a quantitative rather than a 
qualitative nature for DS. However, genes situated in Hsa21 account for a less than 2% of 
total genomic material (Gardiner and Davisson, 2000), leading to the intriguing question of 
how can such a relatively modest quantitative genomic alteration give rise to such serious 
pathological consequences. According to the ‘‘gene dosage effect hypothesis’’, particular 
phenotypic traits associated with T21 are direct consequences of the imbalance of  
individual genes located on the triplicate chromosome (Pritchard and Kola, 1999, 
Antonarakis et al., 2001, Antonarakis et al., 2004). In agreement with this hypothesis is the 
identification of several “dosage-sensitive” regions, including genes and noncoding 
conserved elements, across the length of Hsa21, that have been shown to be sufficient for 
induction of typical features of DS individuals (Korbel et al., 2009, Lyle et al., 2009). On the 
contrary, the “amplified developmental instability hypothesis” postulates that triplication of 
a relative small number of genes disrupts global gene expression and regulation of 
intracellular signaling pathways, leading to deleterious effects on development and function 
(Hall, 1965, Shapiro, 1983, Pritchard and Kola, 1999, Moldrich et al., 2007). The main 
strength of this hypothesis is in the interpretation of DS as a “genomic disorder”, which 
suggests overlapping underlying mechanisms between DS and other trisomies. A synthesis 
of these opposite approaches proposes that some dosage sensitive genes, whose 
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triplication per se would have only modest effects, may account for the numerous DS 
phenotypes only in combination with other triplicate genes (Olson et al., 2004, Roper and 
Reeves, 2006).  
Similar to other conditions caused by chromosome imbalance, DS afflicts structure 
and function of multiple systems, producing detrimental effects on physical and mental 
health. Additionally, the clinical manifestations of DS change across the lifespan, 
contributing further to the complexity of syndrome (Antonarakis and Epstein, 2006). The 
first line of health problems are congenital malformations that include craniofacial and 
skeletal dysmorphic features with more cosmetic than functional effects (Frostad et al., 
1971, Fischer-Brandies, 1988), and significant cardiovascular (Ferencz et al., 1989) and 
gastrointestinal (Levy, 1991) anomalies that, if not treated properly, could lead to serious 
morbidity. Presence of cancer phenotype is controversial, as at the birth there seems to 
exist an increased risk for myieloproliferative disorders, while in the adulthood prevalence 
of many malignant tumors is decreased (Wechsler et al., 2002). The second line of 
symptoms develops progressively during life and, besides growth retardation, obesity, 
thyroid dysfunction and male sterility (Antonarakis and Epstein, 2006), it refers mostly to 
central nervous system (CNS) dysfunctions. CNS symptomatology of DS starts with central 
hypotonia at birth and continues with delayed cognitive development in infancy and 
childhood, leading to mild to moderate mental retardation that aggravates in adulthood, 
with an additional loss of cognitive abilities due to precocious development of Alzheimer 
disease (AD). Generally, the lifetime of DS individuals is shorter with respect to the normal 
population and its duration is strongly influenced by the constellation of clinical signs that 
vary enormously in prevalence and severity across DS population.  
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Despite the numerous health problems mentioned above, life quality of people living 
with DS has been improved significantly due to enhanced medical and social care, which 
also resulted in an increased life expectancy from 12 years in 1940s to the current 60 years 
and over (Glasson et al., 2002, Roizen and Patterson, 2003, Bittles and Glasson, 2004, Bittles 
et al., 2007, Lott and Dierssen, 2010). However, CNS abnormalities are still orphan of an 
effective therapy, with ID being the most significant obstacle to an independent life for DS 
individuals. The availability of animal models in the field of DS basic research has started to 
reveal underlying mechanisms of T21 that contribute to the etiology of CNS dysfunction and 
cognitive impairment, providing the basis for designing of clinical trials aiming at the 
amelioration of mental abilities (Reeves and Garner, 2007, Gardiner et al., 2010, Wetmore 
and Garner, 2010, Rissman and Mobley, 2011, Dierssen, 2012, Haydar and Reeves, 2012, 
Ruparelia et al., 2012). 
 
2.1.2. MODELING DOWN SYNDROME IN MICE  
 
The basis for modeling DS in mice is a conserved synteny between the long arm of Hsa21 
and mouse chromosomes 16 (Mmu16), 17 (Mmu17) and 10 (Mmu10) (Pletcher et al., 2001). 
The long arm of Hsa21 is approximately 33.7 Mb in length and contains ~ 430 protein-coding 
genes, of which ~175 have a homolog in the mouse genome. The distal end of Mmu16 
carries the largest homolog region containing 37Mb. This region spans from Rbm11 to 
Znf295 and is composed of ~115 orthologous genes with a subset of them, such as Ncam2, 
App, Grik, Sod, Synj1, Olig1, Olig2, Dyrk1a, Girk2, Bace2, being involved in brain 
development and functioning (Dierssen, 2012, Haydar and Reeves, 2012, Ruparelia et al., 
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2012). The two remaining homolog regions are identified on Mmu17 and Mmu10 and are 
much smaller, containing 1.1 Mb and 2.3 Mb and consisting of 19 and 41 orthologous genes, 
respectively (Das and Reeves, 2011) (Figure 1).  
 
Figure 1. Mouse models of Down syndrome. HSA21 is syntenic with three regions on the mouse genome: 
mouse chromosomes 16 (Mmu16), 17 (Mmu17) and 10 (Mmu10). Modified from Wiseman et al., Human 
Molecular Genetics, 2009 
The spontaneous Robertsonian translocations of Mmu16 naturally occurs in mice 
(Gropp et al., 1975) and this trisomy for Mmu16 (Ts16) has been considered the first model 
of DS. However, Ts16 model has a limited experimental use due to its very low postnatal 
viability, probably caused by trisomy of portions of Mmu16 that show sinteny with genes 
encoded by Hsa3, 8, 12, 6 and 22, which are not involved in etiology of DS (Moore and 
Roper, 2007). Genetic engineering of different segments of Hsa21-orthologues genes 
resulted in the availability of a comprehensive set of transgenic strains carrying those genes 
that show synteny with Hsa21 (Sérégaza et al., 2006, Rueda et al., 2012). Importantly, these 
transgenic strains outlive Ts16 mice and may be studied at any developmental stage and 
across the entire lifespan. 
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The most important group of transgenic DS models encompasses mouse lines with 
triplication of various portions of the distal end of Mmu16. The most widely used and 
characterized model is Ts65Dn, which carries segmental trisomy in a form of small 
chromosome produced by a Robertsonian translocation of Mmu16 to Mmu17. Trisomy in 
this model expands from Mrpl39 to Znf295 (Kahlem et al., 2004) and results in a dosage 
imbalance for ~104 genes conserved on Mmu16. Introduction of this model has been 
fundamental as it demonstrated for the first time that trisomy for syntenic genes of Hsa21 
gives raise to DS-related outcomes in mice (Reeves et al., 1995). A detailed phenotypic 
characterization of Ts65Dn mice revealed a number of abnormalities in cognitive 
performance and brain morphology similar to those observed in people with DS. These 
findings have encouraged the use of Ts65Dn mouse as a standard to compare the incidence 
and severity of trisomic phenotypes reported in mouse models that came afterward 
(Holtzman et al., 1996, Baxter et al., 2000, Richtsmeier et al., 2000, Cooper et al., 2001, 
Rueda et al., 2005, Lorenzi and Reeves, 2006, Moore, 2006, Roper and Reeves, 2006). 
Additionally developed partial trisomies carry smaller set of genes compared to 
Ts65Dn mice. In the case of the Ts1Cje model, the trisomic segment spans from Sod1 to 
Znf295 and counts for ~81 orthologous (Sago et al., 1998), while the Ts1Rhr model has a 
triplication for even a smaller region composed of ~33 genes expanding from Cbr1 to Orf9 
(Olson et al., 2004). Ts1Cje and Ts1Rhr mice also show cognitive impairments, but the 
severity of their deficits is generally attenuated in comparison with Ts65Dn (Sago et al., 
1998, Olson et al., 2007, Belichenko et al., 2009).  
The models that are trisomic for the two remaining syntenic regions of Hsa21 
mapped on Mmu17 and Mmu10 have been used to provide additional insights into the 
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genetic basis of DS. The Ts1Yah mouse carries three copies of 12 genes, spanning from 
U2af1 to Abcg1, of the Mmu17 syntenic to the sub-telomeric region of Hsa21 (Pereira et al., 
2009). This model has been created in order to understand how the telomeric region of 
Hsa21 contributes to DS phenotype. The effects of trisomy on learning and memory in 
Ts1Yah model are contradictory as some aspects of cognitive performance are impaired, 
while other are even improved with respect to euploid controls, emphasizing the concept 
that a complex interaction between genes underlies behavioral alterations in trisomic mice 
(Pereira et al., 2009). Interestingly, the Ts2Yey model, that contains triplication for 41 genes 
of the Mmu10 region which is homologue to the Hsa21 telomeric end, does not show any 
cognitive impairment (Yu et al., 2010). Recently, a ‘triple trisomy’ model, the 
Ts1Yey;Ts2Yey;Ts3Yey mouse, has been developed. The Ts1Yey;Ts2Yey;Ts3Yey mouse is the 
first model with a dosage imbalance for all the Hsa21 orthologous found in the mouse 
genome and it carries in triplicate the syntenic segments from all three mouse 
chromosomes, Mmu16, Mmu17 and Mmu10 (Yu et al., 2010). Nevertheless, the revealed 
brain phenotype of this model is very close to the Ts65Dn  justifying the use of the Ts65Dn 
mouse as the referent murine model for DS (Yu et al., 2010).  
Given that the cognitive performance is the most compromised function in DS, the 
behavioral phenotypes of DS models have been thoroughly assessed to establish their 
relevance for the human condition. Particularly, impairments of spatial and recognition 
learning and memory have been studied in depth by use of a battery of behavioral tests that 
have helped to identify the hippocampus as the brain region specifically affected by trisomy 
in mice (Das and Reeves, 2011). In addition to behavioral evaluations, hippocampal 
morphological and electrophysiological correlates of cognitive deficits have been studied in 
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DS models revealing a clear relationship between the number of trisomic genes that are 
orthologous to Hsa21 and the level of expression of functional and structural abnormalities.  
 
2.1.3. COGNITIVE AND BEHAVIORAL IMPAIRMENTS – COMPARISON BETWEEN 
AFFECTED HUMANS AND Ts65Dn MICE 
 
Humans  
Difficulties in intellectual functioning are the most striking feature of DS. The major obstacle 
to an independent life in DS patients are limitations in cognitive performance that are 
additionally complicated by functional difficulties coming from various areas, such as 
linguistic, social, motor, and sensory (Dierssen, 2012). However, similarly to other genetic 
disorders associated with ID, different domains of intellectual processing in DS are not 
affected to the same level by T21, leading to a complex cognitive profile characterized by 
specific weaknesses and strengths (Fidler et al., 2006).  
Cognitive impairments in DS could be classified into those that are a product of 
disrupted neural development resulting in retardation of learning and memory from birth, 
and those that occur in adulthood as a consequence of accelerated neurodegenerative 
processes (Contestabile et al., 2010). DS individuals during the course of childhood and 
adolescence develop mild to severe ID that, when expressed with the Intelligence Quotient 
(IQ), falls into the range from 30 to 70 (Vicari et al., 2000, Vicari et al., 2004, Vicari et al., 
2005). Cognitive development of DS infants begins relatively typically and the first delays are 
observed at the age of two years which may be associated with the myelination lag at this 
developmental stage (Koo et al., 1992). One of the key features of the overall slowdown in 
maturation of learning abilities for children with DS are difficulties in the maintenance of 
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acquired skills and a persistent use of counterproductive strategies for novel problem 
solving tasks (Wishart, 1993).  
Learning deficits in DS children refer to both short-term and long-term memory 
(Carlesimo et al., 1997, Vicari et al., 2000, Brown et al., 2003, Vicari et al., 2005, Dierssen, 
2012). When assessed with tasks requiring low processing levels, visuospatial components 
of short-term and working memory tend to be speared in contrast to verbal processing, 
which instead demonstrates significant deficits respect to age-matched controls (Vicari et 
al., 1995, Jarrold et al., 1999, Vicari et al., 2006). As the task becomes more demanding, 
certain impairments emerge also in the visuospatial skills, and those reported for verbal 
processing worsen (Lanfranchi et al., 2004, Visu-Petra et al., 2007). Strengths and 
weaknesses are also present in domain of long-term memories. Explicit memory is 
significantly compromised in DS children due to poor information encoding, impaired 
retrieval abilities and attention deficits (Carlesimo et al., 1997, Brown et al., 2003, Krinsky-
McHale et al., 2008), whereas learning abilities for tasks requiring implicit memory 
processing seem to be preserved (Vicari et al., 2000). This is in agreement with a different 
mechanism underlying this two types of memory formation, as implicit memory is a more 
automatic process based on low levels of attention, while explicit memory requires a high 
degree of attention to carry on intentional learning and develop successful retrieval 
strategies.  
Impairment of long-term memory in DS has been associated with hippocampal and 
prefrontal lobe dysfunctions. Deficit in spatial long-term memory reported in pre-school DS 
children assessed by delayed recall of place learning task (Pennington et al., 2003) has 
pointed to altered hippocampal function, whereas impairment of non-verbal reasoning 
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ability and attention has indicated a specific executive control defect due to abnormal 
prefrontal functioning, supporting the concept that ID in DS is differentially affected by the 
degree of required control (Rowe et al., 2006). A high prevalence of behavioral disinhibition, 
illustrated by hyperactivity, aggression, stubbornness, disobedience, impulsivity and already 
mentioned attention deficits (Dykens et al., 2002), is also indicative of prefrontal 
dysfunctions in DS. Recognition memory, another type of explicit memory partially 
dependent on hippocampus (Yonelinas et al., 2005) and frontal lobe (Neufang et al., 2006) 
integrity, is also affected in DS. DS children perform normally in the task of matching 
photographs of simultaneously presented faces, but perform significantly worse in the more 
demanding task of matching faces to non-present people (Wishart and Pitcairn, 2000). Thus, 
similarly to described working memory deficits, the level of task difficulty determines the 
quality of recognition memory performance, indicating that in DS cognitive deficits may be 
generally more pronounced in challenging situations. 
 In addition to developmental ID, DS patients may undergo additional cognitive 
decline with aging and develop precocious AD (Nieuwenhuis-Mark, 2009). Although at the 
neuropathological level virtually all subjects with DS develop typical hallmarks of AD during 
adulthood (Hof et al., 1995, Folin et al., 2003, Nadel, 2003, Lott and Head, 2005), only a 
portion of patients demonstrate clinical signs of dementia (Devenny et al., 1996, Devenny 
and Krinsky-McHale, 1998, Devenny et al., 2000). Clinical progression of AD in DS has some 
similarities with dementia onset in the general population, with confusion, forgetfulness, 
impairment of recent memories and a relative preservation of distant memories at early 
stages of disease (Deb et al., 2007). On the other hand, the signs of frontal lobe dysfunction, 
such as indifference, apathy, depression, socially-deficient communication and impaired 
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adaptive functioning (Zigman et al., 1996, Lott and Head, 2001, Ball et al., 2006), may be 
expressed during initial phase of AD in some cases of DS (Deb et al., 2007, Ball et al., 2008), 
while among the general population these clinical manifestation typically occur only in a late 
phase of AD. 
As discussed above, frontal lobe abnormalities and defective executive functions 
have been also reported in young DS subjects (Rowe et al., 2006), emphasizing the (Burt et 
al., 1992)diagnostic difficulties in detecting cognitive decline caused by dementia in the 
context of ID  (Nieuwenhuis-Mark, 2009). Moreover, in DS the risk of developing some 
forms of mental disease increases over time (Dykens et al., 2002), representing an 
additional confounding factor in the correct diagnosis of the cognitive deficit. Depression is 
the most common psychiatric problem among young adults affected by DS (Myers and 
Pueschel, 1991, Collacott et al., 1992) and its progression may lead to additional decline in 
adaptive behavior and cognitive performance during mid and late adulthood (Burt et al., 
1992). 
Ts65Dn  
Similarly to human DS subjects, disruption of neural development processes leads to early 
cognitive impairments also in Ts65Dn mice (Bianchi et al., 2010), with a further worsening 
occurring in adulthood due to neurodegenerative processes (Hyde and Crnic, 2001, Faizi et 
al., 2011) 
Short-term working memory has been assessed by spontaneous alternation tasks, 
revealing a reduced performance in Ts65Dn mice (Fernandez et al., 2007) and resembling 
short-term memory deficits observed in DS individuals (Lanfranchi et al., 2004, Visu-Petra et 
al., 2007). Furthermore, Ts65Dn mice, as well as persons with DS, are characterized by a 
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functional dissociation between implicit and explicit long-term memory. Namely, Ts65Dn 
mice perform similarly to wild type (WT) mice in implicit memory tasks, as indicated by 
normal acquisition and maintenance of skills in the rotarod performance test (Hyde and 
Crnic, 2001, Fernandez et al., 2007).  
On the other hand, Ts65Dn mice demonstrate selective impairments in explicit 
learning and memory tasks. Two prototypical domains of explicit memory that can be 
delineated in rodents through a variety of behavioral tasks are spatial and recognition 
learning and memory. These experimental paradigms depend on the functional integrity of 
the medial temporal lobe, composed of the hippocampus and the parahippocampal region, 
the same areas associated with deficits in declarative memory displayed by patients with DS 
(Nelson et al., 2005). The most frequently used test to assess spatial long-term learning and 
memory in Ts65Dn mice is the Morris water maze (MWM). This paradigm evaluates 
visuospatial integration, as mice are trained to find a platform hidden in a tank filled with an 
opaque water, using a complex spatial mapping strategy based on extra- and intra-maze 
cues  (Morris, 1984, Redish and Touretzky, 1998). It has been repeatedly shown that Ts65Dn 
mice perform similarly to euploid mice in a cued task that does not involve visuospatial 
integration because the hidden platform is marked with visible cues such as a flag 
(Escorihuela et al., 1998, Sago et al., 2000, Bimonte-Nelson et al., 2003, Rueda et al., 2008). 
This indicates that motivation is not affected in Ts65Dn mice which have sufficient motor 
and visual skills to reach a visible platform. However, in the hidden-platform task Ts65Dn 
mice display significant navigational impairments and a general inability to create successful 
strategies to find and remember the position of the platform (Escorihuela et al., 1995, 
Reeves et al., 1995, Demas et al., 1996, Holtzman et al., 1996). 
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It is important to note that deterioration in the performance of Ts65Dn mice in 
MWM may be partially due to a stressful nature of the test as a certain degree of 
aversiveness is an integral part of MWM (Stasko and Costa, 2004). This indicates that 
challenging situations are more prone to reveal deficits not evident in stress-free 
circumstances. This is also supported by the recent finding that Ts65Dn mice show identical 
outcomes as WT mice in place preference and place avoidance learning tasks when tested in 
the home cage environment, which can be considered a stress-free condition (Faizi et al., 
2011). However, recognition memory evaluated by non-aversive object recognition tests is 
also impaired in Ts65Dn mice, illustrating the persistence of some cognitive deficits even in 
low stress circumstances. Ts65Dn mice exhibit significant deficits in the simple version of the 
novel object recognition task (a simple protocol involving a pair of identical objects during 
the familiarization phase), but a complete inability to distinguish novel and familiar objects 
in the complex version of the test (a more challenging protocol involving a pair of different 
objects during the familiarization phase). Importantly, the profile of this impairment is in 
accordance with previously described neuropsychological studies in human DS, reporting 
more pronounced difficulties in intellectual processing in DS patients with increasing task 
demands (Lanfranchi et al., 2004, Visu-Petra et al., 2007).  
The majority of the above mentioned behavioral tests refers to young adult Ts65Dn 
mice at the age of  3-4 months, but for some tasks longer follow up studies have been 
performed, allowing to uncover an additional amount of cognitive performance decline with 
age (Hyde and Crnic, 2001, Faizi et al., 2011). This is reminiscent of the cognitive 
deterioration due to an early onset of AD among DS individuals. 
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2.1.4.  ALTERED SYNAPTIC PLASTICITY AS A CENTRAL MECHANISM OF 
NEUROPHYSIOLOGICAL IMPAIRMENST IN DOWN SYNDROME 
 
Learning and memory, key cognitive processes affected by DS, have been strongly 
associated with synaptic plasticity mechanisms (Bliss and Collingridge, 1993, Hofer and 
Bonhoeffer, 2010). Synaptic plasticity refers to the physiological ability of synapses to alter 
their structure, composition or function in response to changes in neural activity. Depending 
on the timing and strength of pre- and postsynaptic activity, synapses can either be 
strengthened or weakened, providing a potential mechanism for memory formation and 
storage (Dan and Poo, 2006). The connection between synaptic plasticity and learning and 
memory is typically studied within the hippocampus, as this brain region is critically involved 
in acquisition, storage and recall of spatial information (Nadel and Bohbot, 2001, Kesner, 
2007, Moser et al., 2008). Consequentially, any structural or functional abnormalities in 
hippocampus that limit the capability of synapses to undergo plastic changes would be 
expected to compromise spatial cognition. The behavioral and morphological alterations 
associated with trisomic hippocampus, like dendritic pathology (Becker et al., 1986, 
Takashima et al., 1989) and impairments in spatial learning and memory (Pennington et al., 
2003, Edgin et al., 2010), suggest an ineffective synaptic plasticity in DS. There is evidence 
indicating that plasticity is reduced also in the motor cortex of DS individuals (Battaglia et 
al., 2008). Moreover, functional MRI (fMRI), performed during cognitive processing tasks 
involving multiple brain regions, reveals abnormal neural activation patterns in DS children 
and young adults (Losin et al., 2009, Jacola et al., 2011). These data suggest that an 
impairment of synaptic plasticity may not be exclusively an hippocampal phenomenon, but 
a general characteristic of DS brain. Consistent with this idea is also the general defect in 
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synaptogenesis that starts to be evident from the fetal period (Becker et al., 1991) and 
persists until adult age (Petit et al., 1984, Takashima et al., 1994, Weitzdoerfer et al., 2001). 
Since it is very difficult to evaluate synaptic function in humans, the animal models have 
provided important insights into the neurobiology of aberrant plastic mechanisms in DS.   
The best established experimental models for investigating the synaptic base of 
learning and memory in rodents are long-term potentiation (LTP) and long-term depression 
(LTD), that refer to long-lasting up- or downregulation of synaptic strength, respectively, 
after an appropriate electrical stimulus of hippocampal circuits in the brain slice 
preparation. It is conventionally believed that the ability of hippocampal circuits to undergo 
LTP and LTD is necessary for the processes of learning and memory; thus, alteration in the 
expression of these two model of synaptic plasticity is considered an electrophysiological 
correlate of cognitive deficits.  
Multiple lines of evidence indicate that synaptic plasticity is altered in adult Ts65Dn 
mice. The phenomenon of LTP has been studied in detail in this mouse model and its 
reduction has been reported in the hippocampal CA1 and DG regions (Siarey et al., 1997, 
Kleschevnikov, 2004, Costa and Grybko, 2005, Das and Reeves, 2011, Kleschevnikov et al., 
2012). Importantly, LTP abnormalities have been also observed in various rodent models of 
other forms of developmental ID (DID) (Costa et al., 2002, Asaka et al., 2006, Moretti et al., 
2006, Guy et al., 2007) and AD (Chapman et al., 1999, Larson et al., 1999, Moechars et al., 
1999, Origlia et al., 2006, Houeland et al., 2010), indicating that the impairment of synaptic 
plasticity in the case of DS may underlie both ID emerging during childhood and additional 
cognitive decline due to precocious AD in adulthood. In addition to LTP failure, abnormal 
augmentation of LTD has been reported from hippocampal slices of Ts65Dn mice (Siarey et 
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al., 1999, Scott-McKean and Costa, 2011) further strengthening a link between alteration of 
synaptic plasticity in hippocampus and poor cognitive performance displayed by this DS 
animal model. The breakthrough discovery in this field was the demonstration that the 
reduction of LTP in adult Ts65Dn mice is due to excessive inhibitory transmission in the 
hippocampus (Kleschevnikov et al., 2004, Fernandez et al., 2007) suggesting that these 
imbalance between excitatory and inhibitory inputs may be the core mechanism  of disrupted 
neural plasticity and cognitive processing in DS.  
 
2.2. EFFECTS OF ENVIRONMENTAL ENRICHMENT ON BRAIN IN HEALTH AND 
DISEASE 
 
The development and maturation of the mammalian brain are governed by complex genetic 
and epigenetic programs that enable temporal and spatial integration of molecular and 
cellular signals necessary for the construction of appropriate neural networks. Once formed, 
neural circuitries undergo continuous refinements through motor, sensory, social and 
cognitive interactions with the environment during the whole lifespan. In this way, genes 
and environment act together to establish and maintain optimal brain function. Thus, any 
modification of this complex gene-environment interaction would be expected to have  
profound impact on CNS. This chapter will address the spectrum of beneficial effects elicited 
by environmental enrichment (EE) paradigm. EE refers to the housing conditions that enable 
enhanced cognitive, motor, social and sensory stimulation of animals in comparison with 
standard laboratory environment (Rosenzweig and Bennett, 1996, van Praag et al., 2000, 
Sale et al., 2009).  
It has been clearly demonstrated that EE is able to dramatically affect the functional, 
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anatomical and molecular properties of the CNS, both during the CPs and in adulthood 
(Baroncelli et al., 2010). Important insights into the mechanisms underlying these 
remarkable effects have been provided by studies focused on the visual system (Sale et al., 
2009). At early stages of brain development, EE triggers a marked acceleration in the 
maturation of the visual system with enhanced maternal care acting as a fundamental 
mediator of the enriched experience in the newborn. In the adult brain, EE stimulates 
plasticity in the cerebral cortex, promoting the recovery of visual functions in amblyopic 
animals. The broad spectrum of neural effects exerted by EE is considerable given that it 
activates multiple molecular responses including reduced intracerebral inhibition, enhanced 
neurotrophin expression and epigenetic changes at the level of chromatin structure.  
These results shed new light on the potential of EE as a non-invasive strategy to 
ameliorate deficits in the development of the CNS and to treat neurodegenerative disorders 
associated with aging (Nithianantharajah and Hannan, 2006, Baroncelli et al., 2010).  
 
2.2.1. NEURAL CONSEQUENCES OF ENVIRONMENTAL ENRICHMENT 
 
EE is classically defined as “a combination of complex inanimate and social stimulation” 
(Rosenzweig et al., 1978). Enriched animals are reared in large groups and housed in 
spacious cages where running wheals and a variety of differently shaped objects are 
introduced and changed frequently. In this way the animals experience a multi-
sensory/cognitive stimulation, increased physical activity and enhanced social interactions 
that improve the quality of animals’ life and promote their natural explorative behaviors 
(Figure 2). Thus, EE has been created as a gain-of-function paradigm that allows to 
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understand how increased levels of environmental stimulation may influence brain 
development and plasticity.  
 
Figure 2. Environmental enrichment and the effects of enhanced sensory, cognitive and motor stimulation 
on different brain areas. Enrichment can promote neuronal activation, signalling and plasticity throughout 
various brain regions. Modified from Nithianantharajah and Hannan, Nature Reviews Neuroscience, 2006. 
 
EE exerts profound effects on the adult healthy brain. The most prominent outcome 
of this experimental paradigm is an enhancement of neural plasticity, the ability of the 
nervous system to change in response to experience. While neural plasticity is a 
fundamental property of the brain, it has been shown that  EE is able to elicit structural and 
functional changes in the brain that promote brain plasticity (van Praag et al., 2000).  
Multiple studies reported that EE is able to modify animals’ behavior leading to an 
improvement in complex cognitive functions, particularly learning and memory (Rampon 
and Tsien, 2000), and positively affecting the animals’ emotional and stress reactivity 
(Chapillon et al., 2002). In line with these ameliorations of cognitive performance is the 
increased potential for synaptic refinement displayed by enriched animals, as illustrated by 
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facilitation of LTP induction in the hippocampus (van Praag et al., 2000).  
This functional improvement is accompanied by prominent changes at the 
anatomical level. Robust increments in cortical thickness and weight and modifications of 
neuronal morphology, including increased dendritic arborisation, number of dendritic 
spines, synaptic density and postsynaptic thickening, have been observed in several regions 
of the brain, particularly in the hippocampus and the occipital cortex (Mohammed et al., 
2002). Moreover, exposure to EE enhances hippocampal neurogenesis and the integration 
of newly born cells into functional circuits, which in turn may increase the existing potential 
of mature brain for learning and memory (van Praag et al., 2000).  
At the molecular level, EE causes a significant change in the expression of a large set 
of genes involved in neuronal structure, excitability, synaptic transmission and plasticity 
(Rampon et al., 2000). Further, EE modulates the synthesis and secretion of neurotrophic 
factors throughout the brain and affects the cholinergic, serotoninergic and noradrenergic 
signaling (Rosenzweig and Bennett, 1969, Rasmuson et al., 1998, Ickes et al., 2000, Naka et 
al., 2002). Although the major part of EE studies have been mainly focused on rodents, 
similar effects have been reported in several species of mammals, such as gerbils, ground 
squirrels, rabbits, cats and primates (Rosenzweig and Bennett, 1969, Cornwell and 
Overman, 1981, Hansen and Berthelsen, 2000, Kozorovitskiy et al., 2005, Jansen et al., 
2009). 
 
2.2.2. BENEFICIAL EFFECTS OF ENVIRONMENTAL ENRICHMENT ON FUNCTIONAL 
OUTCOME IN Ts65Dn MICE 
 
The positive effects of EE paradigm occur in the areas of sensory processing, motor 
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performance, social-emotional behavior and learning and memory. Deficits in these 
functional domains may be diagnosed in neurodevelopmental and neurodegenerative 
disorders and are often associated with an altered potential of neural circuits to undergo 
synaptic modifications (Battaglia et al., 2007, Bagetta et al., 2010, Orth et al., 2010, West 
and Greenberg, 2011, Zoghbi and Bear, 2012). Given that EE normalizes brain plasticity 
through multiple mechanisms, such as correction of excitatory/inhibitory disbalance, 
enhancement of neurotrophin signalling and epigenetic modifications, it is not surprising 
that this non-pharmacological strategy may be successfully employed to prevent, delay 
and/or ameliorate the symptoms of many neurodevelopmental and neurodegenerative 
disorders, despite their quite various etiologies (Nithianantharajah and Hannan, 2006, 
Baroncelli et al., 2010a). Based on these findings, EE emerges as a very attractive and 
promising therapeutic approach for both neurodevelopmental and neurodegenerative 
deficits associated with DS. 
 Indeed, there is strong scientific evidence that the Ts65Dn mice, the animal model 
of DS addressed in detail in the first chapter, may benefit from the exposure to EE. In the 
very recently published paper it has been reported that early EE, starting already during the 
period of pregnancy, resulted in a normalization of declarative memory abilities and 
hippocampal plasticity in trisomic offspring (Begenisic et al., 2015). The positive effects of EE 
on Ts65Dn phenotype were not limited to the cognitive domain, but also included a rescue 
of visual system maturation. The beneficial EE effects were accompanied by increased level 
of neurotrophins (BDNF) and correction of over-expression of the GABA vesicular 
transporter vGAT, indicating normalization of inhibitory transmission. Interestingly, early EE 
led to a robust increase in maternal care levels displayed by enriched Ts65Dn mothers, 
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suggesting that maternal behavior may be the key mediator of the earliest effects of EE on 
brain development and maturation. These findings from animal model are in line with a 
recently published pilot study that explores the effects of an early multi–sensory 
intervention on the development of visual function in infants with DS (Purpura et al., 2014). 
It has been reported that early EE, in the form of infant massage, affects maturation of 
visual functions in human infants, when applied during a period of high brain plasticity. 
Together these two studies (Purpura et al., 2014, Begenisic et al., 2015) highlight the 
beneficial impact of early environmental stimuli on functional CNS deficits in developing DS 
subjects. 
Importantly, the beneficial effects of EE on cognitive performance and synaptic 
plasticity have been also reported in the Ts65Dn mice that have been enriched in adulthood. 
It has been shown that increased sensory-motor stimulation in young adult Ts65Dn mice (2 
months old) through EE for six weeks is able to reduce brain inhibition levels and promote 
recovery of spatial memory abilities, hippocampal synaptic plasticity, and visual functions 
(Begenisic et al., 2011). Similar effects on adult Ts65Dn mice and amelioration of 
neurobiological phenotype have been found also after 8 weeks of fluoxetine treatment, a 
selective serotonin reuptake inhibitor (SSRI). It has been reported that a chronic treatment 
with fluoxetine administered in the drinking water normalizes GABA release and promotes 
recovery of spatial memory abilities, spatial working memory for alternation, and 
hippocampal synaptic plasticity in young adult Ts65Dn mice (Begenisic et al., 2014). These 
findings are not surprising since it has been shown that chronic treatment with fluoxetine 
activates an array of molecular pathways which are found to be activated as well in animals 
exposed to EE conditions (Vetencourt, 2008, Castren et al., 2012). Therefore, 
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pharmacological targeting of the molecules that mediate the benefits of EE, aiming at 
reproduction or strengthening of its positive effects, may be a good alternative strategy to 
promote brain health and plasticity (McOmish and Hannan, 2007, Pang and Hannan, 2013). 
These two studies (Begenisic et al., 2011, Begenisic et al., 2014) clearly indicate the 
possibility to ameliorate, in adulthood, neurological phenotypes associated with early 
neurodevelopmental disorders, a concept that is attracting a large interest for its potential 
in clinical application (Ehninger et al., 2008, Silva, 2009).  
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3 AIMS OF THE THESIS AND EXPERIMENTAL DESIGN 
 
3.1. AIMS OF THE STUDY 
 
While there is clear evidence about profound beneficial effects elicited by EE on brain 
maturation and function in developing and young adult Ts65Dn mice and DS infants 
(Begenisic et al., 2011, Purpura et al., 2014, Begenisic et al., 2015), little is known about the 
therapeutic potential of this highly physiological and non-invasive paradigm in aged Ts65Dn 
mice and DS persons that display very complex cognitive phenotype – the aggravating effect 
of aging is superimposed on the complications that already manifest in adulthood as a result 
of disrupted neural development. Significant advances in medical treatment and social 
inclusion have increased longevity in people with DS resulting in an increased aging 
population and highlighting the significance of early onset of AD dementia in the context of 
DID. Therefore, it would be of great clinical and social importance to perform novel studies 
that will explore the potential of increased environmental stimulation to ameliorate existing 
cognitive defects and to prevent additional cognitive decline in aging DS subjects. Based on 
this premise, the present behavioral study aims at providing initial evidence about the 
effects of long-term EE on cognitive performance in aged Ts65Dn mice.  
The principal objectives of the study were: 
1. investigation of the effects of long-term EE on spatial learning and memory in  aged 
Ts65Dn and aged-matched control WT mice by use of Morris water maze test; 
2. investigation of the effects of long-term EE on short-term working memory in aged 
Ts65Dn and aged-matched control WT mice by use of  Y maze test. 
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3.2. EXPERIMENTAL DESIGN 
 
I included in the study four experimental groups: WT mice reared in standard condition (SC) 
- WT SC, Ts65Dn mice reared in SC - Ts65Dn SC, Ts65Dn mice reared in EE - Ts65Dn EE, and 
WT mice reared in EE - WT EE. Ts65Dn and WT mice were reared in EE conditions starting 
from 4 months, the age when cognitive deficits were typically displayed by trisomic mice, 
for 8 months. After this period, at the age of 12 months, behavioral analyses were 
performed. Aged-matched Ts65Dn and WT mice were reared in standard conditions for the 
same period of time and underwent the same experimental procedure. General 
experimental design of the study is shown at the Figure 3. Since it has been reported that 
exposing Ts65Dn mice to EE in large groups improves their spatial learning abilities in a sex-
specific manner (Martinez-Cue et al., 2002, Martinez-Cue et al., 2005), I included in this pilot 
study only female mice. 
 
 
 
 
 
Figure 3. General experimental design of the study.  
 
3.3. MATERIALS AND METHODS 
3.3.1. ANIMALS 
 
The transgenic line Ts65Dn was used in this study. Ts65Dn mice carry segmental trisomy in a 
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form of Robertsonian translocation of Mmu16 to Mmu17 (1716) (Figure 4 – A). Segmental 
trisomy provokes male sterility, therefore female carriers of the 1716 chromosome (B6EiC3H 
– a/ATs65Dn) are used to generate trisomic offspring by intercross with (C57BL/6JEi x 
C3H/HeJ) F1 hybrid male mice. Ts65Dn mice are thus maintained on the B6/C3H background 
(Davisson et al., 1993). The marker chromosome 1716 is inherited at expected Mendelian 
frequency, but, due to the perinatal loss, only 20-40% of the offspring of Ts65Dn mothers 
are trisomic at weaning. Moreover, the proportion of trisomic mice per litter decreases with 
the age of the Ts65Dn mother (Roper, 2005). Diploid (WT) mice of the same litter were used 
as a control experimental group (Figure 4 – B).  
 
 
 
 
 
 
 
 
Figure 4. (A) Genome of Ts65Dn mice. Red flag indicates the marker chromosome 17
16
 . (B) Ts65dn mice 
(right) and diploid (WT) littermate.   
The low reproductive outcome of Ts65Dn mice is further compromised by the 
recessive retinal degeneration (rd) mutation that segregates in C3H/HeJ background and 
leads to blindness by ~1 month of age in about 25% of newborns from Ts65Dn mothers. This 
limits the use of rd positive homozygotes in behavioral experiments (Reeves et al., 1995, Das 
and Reeves, 2011). This problem has been recently overwhelmed through the breeding of 
A B 
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Ts65Dn extra chromosome across many generations into a closely related genetic 
background free of rd mutation. Analysis of the effects of this new genetic background on 
mice performance revealed no significant differences in behavioral phenotype respect to 
the original Ts65Dn model (Costa et al., 2010). 
 In the present study the effects of EE in adulthood were investigated on Ts65Dn 
strain free of rd mutation. Ts65Dn mating couples were originally obtained from The 
Jackson Laboratory (Bar Harbor, Maine, USA) and colony of Ts65Dn strain was established. 
The progeny of colonies was genotyped by a quantitative PCR (qPCR) protocol developed by 
The Jackson Laboratory (http://www.jax.org/cyto/quanpcr.html).  
 
3.3.2. DNA EXTRACTION 
 
Genomic DNA was extracted according to the protocol developed by The Jackson 
Laboratory. Tail tips (3 mm) were collected and subsequently digested with 300 ul of 50 mM 
NaOH for 1 h at 98°C, with a brief resuspension after 30min. After incubation, DNA was 
dissolved in 30 ul of 1 M Tris (pH8), resuspended and centrifuged for 6 min at 14000 rpm. 
The supernatant was used for qPCR genotyping and PCR screening for retinal degeneration.   
 
3.3.3. GENOTYPING 
 
All mice obtained from internal colonies were genotyped using real-time qPCR with TaqMan 
probes (Applied Biosystems) specific for the following genes: App, apolipoprotein B (ApoB) 
and myxovirus resistance 1 (Mx1). Genes for App and Mx1 were used as the target (marker) 
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genes, whereas the ApoB gene was used as internal control. The rationale is that App and 
Mx1 are located in the chromosome segment triplicated in Ts65Dn, whereas ApoB is 
mapped on Mmu12. Thus, Ts65Dn samples have three copies of App and Mx1, whereas WT 
samples have only two copies. Both Ts65Dn and WT animals have two copies of ApoB. The 
extra copy of App or Mx1 in trisomic samples is detected by qPCR. The reaction was 
performed on StepOne™ instrument at 50°C for 2 min, 95°C for 10 min, followed by 40 
cycles of 95°C for 15s and 60°C for 1 min. After amplification, the average change in cycle 
threshold (∆∆CT) of the target gene App/Mx1 from that of ApoB in sample animals with 
respect to controls was calculated: 
∆∆CT = (CTApp/Mx1 – CTApoB)trisomic – (CTApp/Mx1 – CTApoB)euploid) 
The ∆∆CT value for App or Mx1 in trisomic samples is < – 0.3. The sequences of 
primers and probes were as follows: 
ApoB   forward primer 5’-CACGTGGGCTCCAGCATT-3’ 
reverse primer 5’-TCACCAGTCATTTCTGCCTTTG-3’ 
probe 5’-CCAATGGTCGGGCACT-3’ 
App      forward primer 5’-TGCTGAAGATGTGGGTTCGA-3’; 
reverse primer 5’-GACAATCACGGTTGCTATGACAA-3’; 
probe 5’-CCATCATCGGACTCAT-3’; 
Mx1     forward primer 5’-TCTCCGATTAACCAGGCTAGCTAT-3’ 
reverse primer 5’-GACATAAGGTTAGCAGCTAAAGGATCA-3’ 
probe 5’-TGGCTTTCCTGGTCGC-3’  
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3.3.4. ESTABLISHMENT OF Ts65Dn MICE COLONY 
 
Since the breeding of transgenic Ts65Dn mice is very complex, the first part of the study was 
focused on the establishment of Ts65Dn colony at animal house of Institute of 
Neuroscience, CNR, Pisa. In order to follow up the quality and quantity of a mouse colony 
and estimate the reproductive potential of Ts65Dn females and perinatal loss of trisomic 
offspring, the progeny was analyzed for following parameters: rate of trisomy and its 
distribution between sexes, litter size at weaning and average weight at p60.  
 
Table 1. Description of Ts65Dn mice colony.  
I found that in our colony chromosome 1716 is inherited at lower rate (31.8 5 % of 
genotyped offspring carried Ts65Dn genotype) than theoretically expected Mendelian 
frequency, but this was in line with data from literature (Roper et al., 2006). I found also a 
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small litter size (4.4) at weaning, probably due to perinatal loss of trisomic offspring. These 
two findings are indicative of a low reproductive potential of a Ts65Dn mice colony and 
highlight difficulties to obtain trisomic experimental group of animals. At p60 there was no 
statistic difference in the average weight between WT and Ts65Dn mice.   
 
3.3.4. ENVIRONMENTAL ENRICHMENT INTERVENTION  
 
EE, a complex rearing environment composed of motor, sensory, cognitive and social 
stimulation, consisted of a large Plexiglas cage (44x62x28 cm) with a wire mesh lid 
containing standard laboratory bedding, several food hoppers, running wheels, and various 
objects of different shape (e.g. tunnels, shelters, stairs) and material (e.g. wood, plastic, 
glass). Once per week the position of food hoppers were changed and the objects were 
completely replaced with others. Every EE cage housed 3-6 females. Standard conditions 
(SC) consisted of a standard Plexiglas laboratory cage (26x42x18 cm) with a wire mesh lid 
containing only standard laboratory bedding. SC cages housed 2-3 females. In both 
experimental conditions mice had ad libitum access to a standard laboratory chow diet and 
tap water throughout the study. All animals were maintained at 12h/12h light-dark cycle 
with lights on at 6 a.m..  
 
3.3.5. MORRIS WATER MAZE 
 
 
Mice (WT SC, n = 14; Ts65DN SC, n = 8; Ts65Dn EE, n = 8; WT EE, n = 13)  were trained for 4  
trials per day and for a total of 6 days in a circular water tank, made from grey 
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polypropylene (diameter, 100 cm; height, 40 cm), filled to a depth of 25 cm with water 
(23°C) rendered opaque by the addition of a small amount of atoxic white paint. Four 
positions around the edge of the tank were arbitrarily designated North (N), South (S), East 
(E), and West (W), which provided four alternative start positions and also defined the 
division of the tank into 4 quadrants: NE, SE, SW, and NW. To avoid possible confounding 
effects due to reduced visual acuity in Ts65Dn mice, the tank was surrounded by a set of 
extra-maze cues in the visual discrimination range detectable by all experimental groups. A 
circular clear Perspex escape platform (diameter, 10 cm; height, 2 cm) was submerged 0.5 
cm below the water surface and placed at the midpoint of one of the four quadrants. The 
hidden platform remained in the same quadrant during training, while the start positions (N, 
S, E, or W) were randomized across trials. Mice were allowed to locate the escape platform 
up to 60 s, and their escape latency was automatically recorded by the Noldus Ethovision 
system. In the last trial of the last training day, mice received a single probe trial, during 
which the escape platform was removed from the tank and the swimming paths were 
recorded over 60 s while mice searched for the missing platform. The swimming paths were 
recorded and analyzed with the Noldus Ethovision system.  
 
3.2.6. SPONTANEOUS ALTERNATION 
 
Spontaneous alternation (WT SC, n = 9; Ts65DN, SC n = 9; Ts65Dn, EE n = 9; WT EE, n = 9) 
was measured using the Y-maze, as described in (Faizi et al., 2011). I used a Y-shaped maze 
which was constructed with three symmetrical gray solid plastic arms at a120-degree angle 
(26 cm length, 10 cm width, and 15 cm height). Mice were individually placed in the center 
38 
 
of the maze. The mouse was allowed to freely explore the three arms for 8 minutes. Arm 
entry was defined as all four limbs within the arm. A triad was defined as a set of three arm 
entries, when each entry was to a different arm of the maze. The maze was cleaned with 
10% ethanol between sessions to eliminate odor traces. All sessions were video-recorded 
for offline analysis. The number of arm entries and the number of triads were recorded in 
order to calculate the alternation percentage (generated by dividing the number of triads by 
the number of possible alternations and then multiplying by 100). 
 
3.2.7. STATISTICS 
 
All statistical analysis was done using SigmaStat Software. Differences between two groups 
were assessed with a two-tailed t test, while differences between two four groups were 
assessed with One-way ANOVA, Two way ANOVA and Two way RM ANOVA, followed by 
multiple comparison procedures Holm–Sidak or Tukey test. 
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4 RESULTS 
 
4.1. LONG-TERM ENVIRONMENTAL ENRICHMENT PROMOTES SPATIAL 
LEARNING  AND MEMORY IN AGED Ts65Dn MICE 
 
I initially assessed spatial memory abilities in MWM task, a hippocampus dependent 
cognitive paradigm in which Ts65Dn mice are known to be severely impaired (Escorihuela et 
al., 1995, Stasko and Costa, 2004, Fernandez et al., 2007). In agreement with data form 
literature, I have also previously reported (Begenisic et al., 2011) that, at 4 months of age, 
Ts65Dn SC mice displayed a significant deficit in this task. The latency to locate the 
submerged platform on the last day of training was longer in Ts65Dn mice reared in 
standard environmental conditions Ts65Dn SC (33.02 ± 8.24 s, n = 6) compared to  WT SC 
mice (14.52 ± 3.34 s, n = 9) (Figure 5). These findings indicate that the deficit in this cognitive 
domain is already evident at the age of the begging of environmental treatment in the 
present study. 
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To assess the strength of spatial learning in young adult animals, I performed on the last trial 
of the last training day a probe trial in which the hidden platform was removed and the 
amount of time spent in the former region of platform was measured. The probe test 
confirmed the spatial memory impairment of Ts65Dn mice: WT mice spent significantly 
longer time in the quadrant where the platform was located during the days of training; in 
contrast, Ts65Dn SC mice showed no preference for the target quadrant, but rather for the 
SE quadrant (i.e. the quadrant corresponding to the start position), due to the initial floating 
* 
Figure 5. Spatial learning deficit  in young adult Ts65Dn mice. (A) Learning curves 
for WT SC (blu, n = 9) and Ts65Dn SC (gray, n = 6) mice. (B) The histogram shows 
latency to locate the submerged platform on the last day of training for the two 
groups (Two-tailed t test showed significant difference p < 0.0). *, statistical 
significance; error bars, s.e.m. Modified from Begenisic et al., 2011. 
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Figure 6. Spatial memory deficit in young adult Ts65Dn mice.  Probe trial for WT SC (blu, n = 9) and 
Ts65Dn SC (gray, n = 6)  mice. Two Way RM ANOVA revealed a statistically significant interaction 
between the genotype group and the pool quadrant (p < 0.001). A Holm-Sidak multiple 
comparison procedure revealed that while Ts65Dn-SC did not show any preference for the target 
(NW) quadrant, WT spent significantly more time in the NW quadrant than in the other 
quadrants. Moreover, the time spent in the target quadrant was shorter in Ts65Dn-SC mice than 
in the other group. *, statistical significance; error bars, s.e.m. Modified from Begenisic et al., 
2011 
 
which was more frequent in this experimental group (Figure 6). A qualitative inspection of 
thygmotaxis did not suggest that this behavior was differentially displayed in the two 
experimental groups. 
 
 
 
 
 
 
 
 
 
 
 
 
In the present study I found the aggravation of MWM spatial learning abilities in trisomic 
mice at 12 months of age. The latency to locate the submerged platform on the last day of 
training was much longer in Ts65Dn SC (41.02 ± 4.47 s, n = 8) when compared to all other 
experimental groups:  WT SC (25.70 ± 323, n = 14), Ts65Dn EE  (25.14 ± 3.89 s, n = 8), and 
WT EE (23.9 ± 3, n = 13), while these three latter groups did not differ (Figure 7). These data 
* * 
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indicate that long-term exposure to EE was able to restore the spatial learning deficit in 
aged Ts65Dn mice.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to evaluate the effects of aging and long-term environmental stimulation on spatial 
memory, on the last trial of the last training day I performed the probe trial in aged animals. 
Both WT SC and Ts65Dn SC mice display poor performance in the probe test and did not 
show preference for the target quadrant. On the other hand, WT EE and Ts65Dn EE mice 
spent more time in the target quadrant, indicating that EE was able to strengthen spatial 
* 
Figure 7. Environmental enrichment promotes spatial learning in aged Ts65Dn mice. (A) Learning 
curves for WT SC (blu, n = 14), Ts65Dn SC (gray, n = 8), Ts65Dn EE (black, n = 8) and WT EE (green, n = 
13). (B) The histogram shows latency to locate the submerged platform on the last day of training for 
the four groups. One Way ANOVA followed by a multiple comparison procedure (Tukey test) showed 
a statistical difference between Ts65Dn SC mice and other three groups (p < 0.05), while other 
experimental groups did not differ between each other. *, statistical significance; error bars, s.e.m 
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memory in both group of aged enriched mice (Figure 8). Finally, qualitative inspection of 
thygmotaxis did not suggest that this behavior was differentially displayed in the four 
experimental groups.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Environmental enrichment promotes spatial memory in Ts65Dn mice. Probe trial for WT SC (blu, n 
= 14), Ts65Dn SC (gray, n = 8), Ts65Dn EE (black, n = 8) and WT EE (green, n = 13) mice. Two Way RM ANOVA 
revealed a statistically significant difference between the genotype group (p < 0.05) and the pool quadrant 
(p < 0.001). A Tukey test revealed that while Ts65Dn SC did not show any preference for the target (SW)  
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Figure 8. Environmental enrichment promotes spatial memory in Ts65Dn mice. Probe trial for WT SC (blu, n 
= 14), Ts65Dn SC (gray, n = 8), Ts65Dn EE (black, n = 8) and WT EE (green, n = 13) mice. Two Way RM ANOVA 
revealed a statistically significant difference between the genotype group (p < 0.05) and the pool quadrant 
(p < 0.001). A Tukey test revealed that while Ts65Dn SC did not show any preference for the target (SW) 
quadrant, both WT EE and Ts65Dn EE mice spent significantly more time in the NW quadrant than in the 
other quadrants (p < 0.05). *, statistical significance; error bars, s.e.m 
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4.2. LONG-TERM ENVIRONMENTAL ENRICHMENT AMELIORATES WORKING 
MEMORY DEFICIT IN AGED Ts65Dn MICE 
 
I used the Y maze to assess spontaneous alternation for spatial working memory. I have 
reported in the recently published paper (Begenisic et al., 2014) that 4 months old  Ts65Dn 
SC mice displayed a significantly lower rate of spontaneous alternation (49.1 ± 3) than WT 
SC (64.4 ± 1.8) mice (Figure 9). As it is true for the MWM performance, these findings 
suggest that the deficit of working memory is also evident before the onset of EE in our 
study.  
 
 
 
 
 
 
 
 
 
 
 
 
As expected, in the present study I confirmed the deficit of Y-maze performance also in 12 
months old aged Ts65Dn mice as their alteration rate (47.3 ± 3.3) was lower than that of 
aged-matched WT SC (67.1 ± 3.6) mice (Figure 6). Importantly, exposure to EE led to the 
* 
Figure 9. Impaired Y maze spontaneous alternation rate in young adult Ts65Dnmice. 
Graph represents alternation rates in the Y-maze of WT SC (blu, n = 11) and Ts65Dn-NT 
(gray, n = 8) mice. Alternation rate in Ts65Dn SC mice was significantly lower than that 
of WT SC (Two-tailed t test, p < 0.001). *, statistical significance; error bars, s.e.m. 
Modified from Begenisic et al., 2014. 
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increased ratio of spontaneous alternation in Ts65Dn EE mice (56.0 ± 2.9) respect to 
trisomic mice reared in SC, while there was no effect of treatment in WT EE animals (62.6  ± 
2.1) (Figure 10). It seems that there is a slight drop in the performance of Ts65Dn SC at 12 
respect (47.3 ± 3.3) to 4 months of age (49.1 ± 3) (Figure 9 and 10), but this difference was 
not statistically significant. 
 
 
 
 
 
 
 
 
 
 
 
 
Together with spontaneous alternation rate, Y maze allows evaluation of animal’s 
explorative behavior by calculating the total number of entries during the test. At the age of 
* 
Figure 10. Amelioration of Y maze spontaneous alternation rate in Ts65Dn EE mice. Graph represents 
alternation rates in the Y-maze of WT SC  (blu, n = 9 ), Ts65Dn SC (gray, n = 9), Ts65Dn EE (black, n = 9) and 
WT (green, n = 9) mice. Alternation rate in Ts65Dn SC mice was significantly lower than that of both WT 
SC and WT EE  (One-way ANOVA, All Pairwise Multiple Comparison Procedure with Tukey  Test, p < 0.05 
in both cases).  An amelioration of spontaneous alternation was found in Ts65Dn EE mice, whose rate 
was not significantly differ from that of both WT SC and WT EE mice (One-way ANOVA followed by a 
Pairwise Multiple Comparison Procedure with Tukey Test, p = 0.069 and 0.435, respectively). *, statistical 
significance; error bars, s.e.m 
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4 month there was no difference for this parameter between WT SC (35.5 ± 2.4)  and 
Ts65Dn (38.3 ± 4.6) mice (Figure 11).  
 
 
 
 
 
 
 
 
 
 
On the other hand, at 12 months of age, I found differences in the total number of Y maze 
entries between four experimental groups in the treatment dependent manner. While there 
was no difference between WT SC (30.0 ± 1.6) and Ts65Dn SC (25.2 ± 4.1) mice in the total 
number of entrances, enriched animals both trisomic Ts65Dn EE (38.7 ± 4.4) and  diploid WT 
EE (45.1 ± 2.2) displayed significantly higher level of exploratory behavior respect to non-
enriched groups of the same genotype (Figure 12). Interestingly, it seems that there is a 
trend towards lower explorative behavior in aged Ts65Dn SC mice (25.2 ± 4.1) respect to 
young Ts65Dn SC mice (38.3 ± 4.6) (Figure 11 and 12).  
Figure 11. Explorative activity in Y maze in young adult animals. Graph represents 
total number of arm entries in the Y-maze of WT SC (blue, n = 11) and Ts65Dn SC 
(gray, n = 8) mice. There was no difference among the total number of entries 
between two experimental groups of mice during the Y-maze testing (Two-tailed t 
Test, p = 0.808). *, statistical significance; error bars, s.e.m. Modified from Begenisic 
et al., 2014. 
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Figure 12. Treatment-dependent increase of exploratory activity in Y-maze in aged mice. Graph 
represents total number of arm entries in the Y-maze of  WT SC  (blu, n = 9 ), Ts65Dn SC (gray, n = 9), 
Ts65Dn EE (black, n = 9) and WT (green, n = 9). While there is no difference between WT SC and Ts65Dn 
SC, and Ts65Dn EE and WT EE  (One-way ANOVA, All Pairwise Multiple Comparison Procedure with 
Tukey Test,  p = 0.734 and p = 0.516, respectively), significant difference was found between WT SC and 
WT EE, and Ts65Dn SC and Ts65Dn EE mice (One-way ANOVA, All Pairwise Multiple Comparison 
Procedure with Tukey Test,  p < 0.05 for both). *, statistical significance; error bars, s.e.m 
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5 DISCUSSION  
 
 
It has been believed for a long time that the consequences of developmental alterations in 
neurogenesis, cell migration and neuronal connectivity caused by T21 are irreversible in 
adulthood and that adult-onset treatment of neurological deficits associated with DS may 
bring a little benefit for the patients. Recent findings in Ts65Dn mice, a well-established 
mouse model of DS, have suggested that it is possible to rescue DS-related cognitive 
dysfunction even in adulthood (Ehninger et al., 2008, Silva, 2009, Bartesaghi et al., 2011). 
Here I provide first evidence that EE may be successfully employed to reverse cognitive 
deficits in aged Ts65Dn mice. 
Investigation of aging in Ts65Dn mice is a very intriguing topic. It allows us to better 
understand a complex interaction between neurophysiological deficits originating from 
aberrant development of CNS and consequences of pathological neural aging associated 
with early-onset AD. Importantly, it also allows us to identify the possible therapeutic 
targets. Since it has been shown that impaired synaptic plasticity is one of the core 
pathological mechanisms of cognitive dysfunction in both DID and AD (see section 
INTRODUTION 2.2.1.), treatment that promotes plastic mechanisms in the brain, such as EE, 
may be successful strategy to promote cognitive performance in aged Ts65Dn mice. Indeed, 
my results from MWM test showed that long-term EE not only prevented additional age-
associated decline of already poor cognitive performance evident at 4 months of age, but 
completely rescued spatial learning in aged Ts65Dn mice. The excellent performance of 
Ts65Dn mice in the probe trial suggested that long-term EE is also able to promote 
consolidation of spatial memory. The beneficial effect of environmental stimulation on 
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spatial memory was evident also in WT mice. While WT mice reared in SC did not show 
preference for the target quadrant in the probe test, a possible aggravating effect of the 
physiological brain aging, enriched WT mice performed as well as young WT mice.  
Aged Ts65Dn mice benefited from EE also in the Y maze. However, the effects of EE 
on cognitive performance in Y maze was not so robust as in MWM, probably due to the 
different sensitivity of neural circuits involved in this test on environmental stimulation. On 
the other hand, I found very interesting effect of EE on explorative behavior of aged mice 
displayed during Y maze testing. Mice of both genotype reared in EE were more stimulated 
to explore novel environment. Since explorative behavior of Ts65Dn mice tends to decline 
with age (see section  RESULTS 4.2.), the increased motivation to explore novelty elicited by 
EE may be responsible, at least  to some extent, for the better cognitive outcome of 
enriched trisomic mice in Y maze. In rodents, generally, loss of interest for novelty is  
considered to be a sign of  depression. Indeed, depression is the most common psychiatric 
problem among young adults affected by DS (Myers and Pueschel, 1991, Collacott et al., 
1992) and its progression may lead to additional decline in cognitive performance during 
mid and late adulthood (Burt et al., 1992). Therefore, it could be hypothesized that long-
term exposure to EE had also an important anti-depressive effect in Ts65Dn mice.   
In order to understand better the nature of the beneficial effects of long-term EE on 
aged Ts65Dn mice it would be of great importance to search for the molecular mechanisms 
activated by environmental stimulation. It has been repeatedly shown that Ts65Dn mice 
have severe cognitive and neural plasticity defects due to excessive inhibition in the 
hippocampus, the brain region critically involved in both behavioral test applied in the 
present study. Since I already reported that increasing sensory-motor stimulation in 
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adulthood through EE reduces brain inhibition levels and promotes recovery of spatial 
memory abilities and hippocampal synaptic plasticity in adult Ts65Dn mice (Begenisic et al., 
2011), a normalization of excitatory/inhibitory balance could be also expected in aged 
trisomic mice.  
Together with a reduction in GABA signaling, other mechanisms could contribute to 
the EE-induced amelioration of cognitive deficits in Ts65Dn mice. In adult rodents, EE is also 
able to enhance the synthesis and secretion of BDNF (Sale et al., 2007, Sale et al., 2009, 
Spolidoro et al., 2009, Sale et al., 2010), a key regulator of neural circuit development and 
function (Park and Poo, 2013). The expression, secretion and actions of BDNF are directly 
influenced by neural activity, while secreted BDNF is capable of mediating many activity-
dependent processes in the mammalian brain, including synapse plasticity and higher 
cognitive functions (Park and Poo, 2013). Ts65Dn mice have defective expression of BDNF in 
the hippocampus (Bianchi et al., 2010) and the frontal cortex (Bimonte-Nelson et al., 2003) 
that could contribute to cognitive dysfunction in this DS model. Thus, it is possible that EE in 
my study also restored BDNF levels, facilitating plastic brain mechanisms and promoting the 
reorganization of affected neural circuits in the mature Ts65Dn brain. 
EE also increases the expression of NGF in WT rodents (Ickes et al., 2000). NGF is a 
neurotrophic factor that enhances the survival, differentiation and function of specific 
neurons of the peripheral and central nervous system during development, adult life and 
aging (Sofroniew et al., 2001). Moreover, it plays a role in the events of degeneration and 
repair of the nervous system in diseases with different etiologies, such as 
neurodegenerative disorders (Tirassa et al., 2003). In adult Ts65Dn mice, an abnormal 
retrograde transport and metabolism of NGF has been associated with a progressive age-
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dependent degeneration of BFCNs and a deterioration of learning and memory processes 
(Cooper et al., 2001, Hyde and Crnic, 2001). Therefore, I could expect that the improvement 
of the cognitive abilities that I found in aged Ts65Dn mice after long-term exposure to  EE 
was accompanied by the normalization of the NGF levels. 
Reduced functional connectivity (Ystad et al., 2011), leading to reduced cortico-
cortical interactions, in particular between primary sensory areas (Golob et al., 2001, 
Stephen et al., 2010) takes place during brain aging and can be a major contributor to the 
functional impairment observed in AD (D'Amelio and Rossini, 2012). Recently it has been 
reported that EE induced profound changes in brain connectivity in aged WT mice (Mainardi 
et al., 2014). These findings were accompanied by an upward shift of the cortical 
excitation/inhibition balance, reduced Aβ oligomers and increased synthesis of the aβ 
degrading  enzyme neprilysin. Therefore, it would be important to analyze functional 
consequences of EE on brain physiology and plasticity also in aged enriched Ts65Dn mice by 
performing in vitro and in vivo electrophysiological recordings and by analyzing molecular 
markers of neural plasticity typically altered by aging and AD, such as soluble Aβ oligomers 
and Aβ-degrading enzyme neprilysin. 
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6 CONCLUSIONS 
 
Major findings from animal models suggest that a number of behavioral, cognitive and 
neurological symptoms associated with neurodevelopmental and neurodegenerative 
disorders may be ameliorated or reduced with exposure to enriched environments, likely via 
mechanisms of experience dependent neural plasticity. 
One may argue that today individuals with DS are already highly stimulated. Indeed, 
in developed countries children with DS almost always undergo a sensory integration 
therapy that, conceptualized as an active process in which the child engages with the 
physical environment to promote neurological change, shares several key principles of EE 
(Reynolds et al., 2010). However, in the past few decades improved medical assistance 
caused a marked prolongation of life expectancy in people with DS, who now may also 
outlive their parents, leading to an emerging risk of social and cognitive impoverishment of 
this population in older age. Moreover, there is a high prevalence of depression in young 
adult DS individuals that may lead to additional decline in adaptive behavior and cognitive 
performance during mid and late adulthood (Burt et al., 1992). Therefore, intervention 
paradigms based on exposure of adult subjects to novel stimuli and learning experiences 
alone, or in a combination with antidepressants such as fluoxetine, may be well suited to 
prevent additional cognitive deterioration in aging individuals with DS. 
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